Related references
Note: Only part of the references are listed.TSC1-mTOR signaling determines the differentiation of islet cells
Li Ding et al.
JOURNAL OF ENDOCRINOLOGY (2017)
GSK-3β Governs Inflammation-Induced NFATc2 Signaling Hubs to Promote Pancreatic Cancer Progression
Sandra Baumgart et al.
MOLECULAR CANCER THERAPEUTICS (2016)
NFATc4 Regulates Sox9 Gene Expression in Acinar Cell Plasticity and Pancreatic Cancer Initiation
Elisabeth Hessmann et al.
STEM CELLS INTERNATIONAL (2016)
Antithetical NFATc1-Sox2 and p53-miR200 signaling networks govern pancreatic cancer cell plasticity
Shiv K. Singh et al.
EMBO JOURNAL (2015)
NFATc1 Links EGFR Signaling to Induction of Sox9 Transcription and Acinar-Ductal Transdifferentiation in the Pancreas
Nai-Ming Chen et al.
GASTROENTEROLOGY (2015)
Projecting Cancer Incidence and Deaths to 2030: The Unexpected Burden of Thyroid, Liver, and Pancreas Cancers in the United States
Lola Rahib et al.
CANCER RESEARCH (2014)
Fibrogenesis in pancreatic cancer is a dynamic process regulated by macrophage-stellate cell interaction
Chanjuan Shi et al.
LABORATORY INVESTIGATION (2014)
Pancreatic Adenocarcinoma
David P. Ryan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
EZH2 Is Associated with Malignant Behavior in Pancreatic IPMN via p27Kip1 Downregulation
Hideyuki Kuroki et al.
PLOS ONE (2014)
Differential activity of GSK-3 isoforms regulates NF-κB and TRAIL- or TNFα induced apoptosis in pancreatic cancer cells
J-S Zhang et al.
CELL DEATH & DISEASE (2014)
GSK-3 as potential target for therapeutic irvention in cancer
James A. McCubrey et al.
ONCOTARGET (2014)
Activator or inhibitor? GSK-3 as a new drug target
Fumi Takahashi-Yanaga
BIOCHEMICAL PHARMACOLOGY (2013)
Recent progress in pancreatic cancer
Christopher L. Wolfgang et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2013)
Macrophage-secreted cytokines drive pancreatic acinar-to-ductal metaplasia through NF-κB and MMPs
Geou-Yarh Liou et al.
JOURNAL OF CELL BIOLOGY (2013)
Presence of Somatic Mutations in Most Early-Stage Pancreatic Intraepithelial Neoplasia
Mitsuro Kanda et al.
GASTROENTEROLOGY (2012)
Oncogenic Kras is required for both the initiation and maintenance of pancreatic cancer in mice
Meredith A. Collins et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
Pancreatic ductal cells in development, regeneration, and neoplasia
Maximilian Reichert et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
Mutant K-Ras increases GSK-3β gene expression via an ETS-p300 transcriptional complex in pancreatic cancer
J-S Zhang et al.
ONCOGENE (2011)
Glycogen synthase kinase (GSK)-3 promotes p70 ribosomal protein S6 kinase (p70S6K) activity and cell proliferation
Sejeong Shin et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Glycogen Synthase Kinase 3-β: A Master Regulator of Toll-like Receptor-mediated Chronic Intestinal Inflammation
Claudia Hofmann et al.
INFLAMMATORY BOWEL DISEASES (2010)
Glycogen synthase kinase 3 beta: can it be a target for oral cancer
Rajakishore Mishra
MOLECULAR CANCER (2010)
KRAS, Hedgehog, Wnt and the twisted developmental biology of pancreatic ductal adenocarcinoma
John P. Morris et al.
NATURE REVIEWS CANCER (2010)
Acute pancreatitis markedly accelerates pancreatic cancer progression in mice expressing oncogenic Kras
Catherine Carriere et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2009)
Context-Dependent Transformation of Adult Pancreatic Cells by Oncogenic K-Ras
Sharon Y. Gidekel Friedlander et al.
CANCER CELL (2009)
Basic-liver, pancreas, and biliary tract
Oliver Strobel et al.
GASTROENTEROLOGY (2007)
Glycogen synthase kinase 3α-specific regulation of murine hepatic glycogen metabolism
Katrina MacAulay et al.
CELL METABOLISM (2007)
Acinar cells contribute to the molecular heterogeneity of pancreatic intraepithelial neoplasia
Liqin Zhu et al.
AMERICAN JOURNAL OF PATHOLOGY (2007)
Functional redundancy of GSK-3α and GSK-3β in Wnt/β-catenin signaling shown by using an allelic series of embryonic stem cell lines
Bradley W. Doble et al.
DEVELOPMENTAL CELL (2007)
Glycogen synthase kinase-3 beta; A new target in pancreatic cancer?
G. Garcea et al.
CURRENT CANCER DRUG TARGETS (2007)
The Nestin progenitor lineage is the compartment of origin for pancreatic intraepithelial neoplasia
Catherine Carriere et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Chronic pancreatitis is essential for induction of pancreatic ductal adenocarcinorna by k-Ras Oncogenes in adult mice
Carmen Guerra et al.
CANCER CELL (2007)
Pancreatic development and disease
David A. Cano et al.
GASTROENTEROLOGY (2007)
Glycogen synthase kinase-3 (GSK3): Inflammation, diseases, and therapeutics
Richard S. Jope et al.
NEUROCHEMICAL RESEARCH (2007)
TSC2 integrates Wnt and energy signals via a coordinated phosphorylation by AMPK and GSK3 to regulate cell growth
Ken Inoki et al.
CELL (2006)
Aberrant nuclear accumulation of glycogen synthase kinase-3β in human pancreatic cancer:: Association with kinase activity and tumor dedifferentiation
Andrei V. Ougolkov et al.
CLINICAL CANCER RESEARCH (2006)
IFN-γ suppresses IL-10 production and synergizes with TLR2 by regulating GSK3 and CREB/AP-1 proteins
Xiaoyu Hu et al.
IMMUNITY (2006)
Pancreatic epithelial plasticity mediated by acinar cell transdifferentiation and generation of nestin-positive intermediates
AL Means et al.
DEVELOPMENT (2005)
Glycogen synthase kinase-3β participates in nuclear factor κB-mediated gene transcription and cell survival in pancreatic cancer cells
AV Ougolkov et al.
CANCER RESEARCH (2005)
Preinvasive and invasive ductal pancreatic cancer and its early detection in the mouse
SR Hingorani et al.
CANCER CELL (2003)
GSK-3: tricks of the trade for a multi-tasking kinase
BW Doble et al.
JOURNAL OF CELL SCIENCE (2003)
Requirement for glycogen synthase kinase-3β in cell survival and NF-κB activation
KP Hoeflich et al.
NATURE (2000)
Share Paper
